Stock comparison
Haemonetics
Inspire Medical Systems
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
HAE
Haemonetics
Market cap
$2.98B
Sector
Healthcare
INSP
Inspire Medical Systems
Market cap
$1.26B
Sector
Healthcare
Overall winner
Haemonetics HAE
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | HAE | INSP | Winner |
|---|---|---|---|
| Warren Buffett | 70B | 50D | HAE |
| Benjamin Graham | 85A | 37D | HAE |
| Philip Fisher | 60C | 48D | HAE |
| Peter Lynch | 54C | 71B | INSP |
| Joel Greenblatt | 31F | 49D | INSP |
| Charlie Munger | 54D | 32F | HAE |
| Terry Smith | 55D | 33F | HAE |
Side-by-side metrics
| Metric | HAE | INSP |
|---|---|---|
| Market cap | $2.98B | $1.26B |
| P/E (TTM) | 24.8x | 9.2x |
| EV/EBIT | 14.1x | 22.3x |
| ROIC (TTM) | 8.37% | 6.24% |
| Gross margin | 55.74% | 85.78% |
| Net margin | 7.29% | 14.33% |
| Revenue CAGR 5y | 7.65% | 40.6% |
| EPS CAGR 5y | 24.62% | - |
| Debt / Equity | 1.5x | 0.0x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
HAE leads on
- Market cap$2.98Bvs $1.26B+58%
- EV/EBIT14.1xvs 22.3x+37%
- ROIC (TTM)8.37%vs 6.24%+25%
INSP leads on
- Debt / Equity0.0xvs 1.5x+98%
- Revenue CAGR 5y40.6%vs 7.65%+81%
- P/E (TTM)9.2xvs 24.8x+63%
- Net margin14.33%vs 7.29%+49%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.